Contact Us
Contact Us

Contact Us Now


Print Page

S&H IP Blog


April 28, 2021 | By Mehdi D. Sheikerz
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit

“AT LEAST ONE …” – The Trend to Clarify Ambiguities

Claim definiteness is increasingly playing a more critical role in claim construction, considering the scrutiny afforded petitioners in inter-partes examination proceedings (IPRs) challenging validity of patents before the USPTO. Even though indefiniteness is not a basis to institute an IPR, claim indefiniteness can cause claim construction confusion. The trend to […]

April 28, 2021 | By Raph Y. Kim
Posted in: S&H IP Blog | U.S. Court of Appeals For The Federal Circuit

Amgen v. Sanofi and Regeneron – Enablement and the In re Wands Factors

On February 11, 2021, the Court of Appeals for the Federal Circuit (“Federal Circuit”) affirmed a district court’s judgment as a matter of law (“JMOL”) that Amgen’s asserted claims to binding affinity of antibodies were invalid for lack of enablement, holding that undue experimentation would be required to practice the […]

April 28, 2021 | By Gene M. Garner II | An Nguyen
Posted in: S&H IP Blog | U.S. Supreme Court

United States v. Arthrex Inc. – Constitutionality of PTAB Judge Appointments

A recent case between two medical device companies raised the question of the constitutionality of the method in which Patent Trial and Appeal Board (PTAB) judges are appointed. PTAB judges are administrative patent judges who examine patents whose validity is questioned and hear appeals from patentees whose patent applications have […]

December 18, 2020 | By David M. Pitcher | John C. Garvey
Posted in: S&H IP Blog | U.S. Supreme Court

Google LLC vs. Oracle America, Inc. – U.S. copyright protection for software interfaces & Amgen Inc. v Sanofi, Aventisub LLC – CAFC heard argument that may influence COVID-19 drug patentability

Please choose article to Read More on: U.S. SUPREME COURT  1 – Google LLC vs. Oracle America, Inc. ”“ U.S. copyright protection for software interfaces U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT  1 – Amgen Inc. v Sanofi, Aventisub LLC ”“ CAFC heard argument that may influence COVID-19 drug […]

STAAS & HALSEY LLP

Firm Logo

1201 New York Avenue, N.W.
7th Floor

Washington, D.C. 20005

T. 202.434.1500 | F. 202.434.1501

View on Google Maps

Back to Top

Privacy Notification

This website uses cookies to improve functionality and performance. If you continue browsing the site, you are giving implied consent to the use of cookies and tracking on this website. See our Privacy Policy for details.